Facioscapulohumeral Muscular Dystrophy
(FSHD)
Clinical Medicine and Molecular Cell
Biology
EDITORS: M
UPADHYAYA & D N COOPER, both at
BIOS Scientific
Publishers
A Member
of the Taylor & Francis Group
March
2004: 250pp
ISBN:
1859962440: £90.00
Facioscapulohumeral muscular dystrophy
(FSHD) is a genetic disorder involving slowly progressive muscle degeneration
in which the muscles of the face, shoulder blades and upper arms are among the
most severely affected. It is the third most common inherited muscular
dystrophy, affecting 1 in 20,000. The search for the molecular basis of the
disease is of great interest to all genetic researchers. The mechanism involves
a deletion of repetitive sequence elements on chromosome 4 which results in the
over-expression of adjacent genes. This volume summarizes the current
understanding of this transcriptional de-repression disorder, including
clinical, molecular and therapeutic aspects.
Table of Contents:
Abbreviations
Acknowledgements
Appendices: The
PETER HARPER,
1. FSHD: INTRODUCTION
MEENA UPADHYAYA & DAVID
N COOPER,
2. FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: HISTORICAL
BACKGROUND
MARK ROGERS,
3. FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: A
CLINICIANS EXPERIENCE
GEORGE PADBERG,
4. MAPPING OF THE FSHD
RUNE FRANTS, LODEWIJK A SANDKUIJL,
SILVERE M van der MAAREL, GEORGE PADBERG,
5. IDENTIFICATION
SILVANA van KONINGSBRUGGEN, SILVERE van
der MAAREL, LEIDEN, THE NETHERLANDS
6. EVOLUTION
JANE HEWITT,
7. SUBTELOMERIC EXCHANGE BETWEEN 4q
RUNE FRANTS, SILVERE van der MAAREL,
8. GENOMIC ANALYSIS THE SUBTELOMERIC REGIONS OF HUMAN
10q
MICHAEL VAN GEEL & JANE HEWITT, NIJMEGEN, THE NETHERLANDS,
MANCHESTER, UK
9. THE DUX
F COPPEE, C MATTEOTTI,
MARCOWYCZ, D FIGLEWICZ, H
DING, ALEXANDER BELAYEW,
10. FSHD: A DISORDER OF MUSCLE
ROSSELLA TUPLER, DAVIDE GABELLINI, WORCESTER, MA, USA
11. THE GENOTYPE/ PHENOTYPE RELATIONSHIPS IN FSHD
PETER LUNT, MEENA UPADHYAYA, MANUELA KOCH &,
12. MOSAICISM
PETRA G M VAN OVERVELD, RUNE R FRANTS, SILVERE van der MAAREL, , LEIDEN, THE NETHERLANDS
13. RETINAL VASCULAR ABNORMALITIES
IN FSHD. A THERAPEUTIC MESSAGE. CLUES FOR PATHOGENESIS?
ROBIN
FITZSIMONS, SYDNEY, AUSTRALIA
14. UNUSUAL CLINICAL FEATURES ASSOCIATED WITH FSHD
YUKIKO HAYASHI,
15. MOLECULAR DIAGNOSIS OF FSHD
LEMMERS RJLF, MJ van der WIELEN, E BAKKAR, S van der MAAREL, LEIDEN, THE NETHERLANDS
16. FSHD MYOBLASTS: IN
VITRO STUDIES
DENISE FIGLEWICZ, KATHY BARRETT, AMANDA
HAEFELE LESKOVAR, JAMES R FORRESTER, JANET E SOWDEN, RABI TAWIL, ROCHESTER, NY,
USA
17. EXPLORING HYPOTHESES ABOUT THE MOLECULAR ETIOLOGY OF
FSHD: LOSS OF HETEROCHROMATIN SPREADING
MELANIE EHRLICH,
18. HISTOLOGICAL, IMMUNOCYTOCHEMICAL, MOLECULAR
MARK ROGERS, MEENA
UPADHYAYA, CAROLINE SEWERY,
19. LINKAGE ANALYSIS IN NON-CHROMOSOME 4-LINKED FSHD
KRISTEN BASTRESS, JEFFREY STAJICH, JOHN
GILBERT, MARCY SPEER,
20. GENDER INFLUENCES IN FSHD; IMPLICATIONS FOR PRECLINICAL
MARIA MANUELA de OLIVEIRA TONINI, MAYANA ZATZ,
21. GENETIC COUNSELLING FOR FSHD
PETER LUNT,
22. SARCOLEMMAL REORGANISATION IN FACIOSCAPULOHUMERAL
MUSCULAR DYSTROPHY
PATRICK REED, NEIL C
PORTER, JOHN STRONG, PAUL W LUTHER, KEVIN M FLANIGAN,
ROBERT
BLOCH,
23. EXPRESSION PROFILING OF FSHD
SARA WINOKUR, YI-
24. THERAPEUTIC TRIALS
RABI
TAWIL, ROBERT GRIGGS,
|
ORDER |
|
Title |
ISBN |
Price |
Quantity |
Total |
|
Facioscapulohumeral Muscular
Dystrophy (FSHD): Clinical Medicine & Molecular Cell Biology |
1859962440 |
£90.00 |
|
|
|
Subtotal |
|
|
Post & Packaging* |
|
|
GRAND TOTAL |
|
Method of Payment
Please tick preferred
payment method:
|
|
I
enclose a cheque payable to Taylor & Francis |
£ |
|
|
Please
debit my debit card (Mastercard/VISA/Diners |
£ |
|
|
Club/EmEx/Switch Card
No:.
.. Expiry
Date:
/
.. Issue No:
(only applies to Switch) Signature:
. |
|
Please
return your order form to:
Abingdon
Oxfordshire
OX14
4RN
Customer
Services for credit card orders:
Telephone
orders: +44 (0) 1264 343071
Fax:
+44 (0) 1235 829011
Email:
book.orders@tandf.co.uk
*
Please add a charge of 5% of order value to your grand total (min charge £1,
max charge £10) for 3-5 days delivery.